Hi-tech prostheses: Personalized movement pattern recognition helps with control

May 8, 2012
Ottobock/MXR-Productions

Surgeons can now, thanks to bionic reconstructions, change the anatomy of patients so that high-tech prostheses can now replace the lost function of limbs very effectively. The control of these prostheses, which is currently linear, may soon be improved even further: with pattern recognition. In collaboration with Ottobock, this method is currently being tested and developed at the Christian Doppler Laboratory for the Restoration of Extremity Functions, which is being opened today (8th May) and which is being headed up by Oskar Aszmann from the Department of Plastic and Reconstructive Surgery at the University Department of Surgery at the MedUni Vienna, part of Vienna General Hospital.   

“Pattern recognition is the latest development in bionic reconstruction. A special computer program, which we have developed in collaboration with Ottobock, will allow the prosthesis user’s highly personalised movement patterns to be stored. The prosthesis will then respond to these movement patterns,” explains Aszmann.  “In other words, the prosthesis recognises when the patient wants to perform a certain movement and then carries it out.”

First, however, the computer has to “learn” to recognise the prosthesis user's intentions: the patients are connected to the computer via electrodes on the skin and prompted to carry out certain movements with their missing extremity, which triggers muscle contractions and impulses. This produces the activity pattern that can be interpreted as a movement that the user intends to make. The high-tech prosthesis can be customised on the basis of these patterns. Says Aszmann: “This system is currently undergoing experimental trials.” But within eighteen months, says the surgeon, we can expect “to be able to send patients home with these .”

Patrick Mayrhofer, Aszmann’s most famous patient so far, is also involved in the research work relating to . The young Austrian was fitted with a high-tech hand prosthesis in May 2011 at the MedUni Vienna. His story was a global media event – from interviews with the BBC to appearances on German TV shows.  In January of this year, the British Ministry of Defence also approached Oskar Aszmann’s team for a bionic reconstruction. In a six-hour operation, a British soldier, who had lost his right arm whilst on duty in Afghanistan, was prepared for an arm . The contact between the British Ministry of Defence and the scientists from Vienna highlights the global renown enjoyed by the MedUni Vienna and Vienna General Hospital as a centre for the restoration of function of the extremities.

The Christian Doppler Laboratory, set up specifically for this purpose, is set to further underpin the MedUni Vienna’s top position in the field. Says Aszmann: “Other research projects will lead to an intensive boost both in terms of technological development and clinical application.” Otto Bock Healthcare Products GmbH, the world market leader for prosthetics technology, is the CD Laboratory's enterprise partner.

Explore further: Why we don't become immune to colds

Related Stories

Why we don't become immune to colds

March 8, 2012
A team of researchers at the MedUni Vienna has discovered why we never become immune to colds, and why we are able to keep catching them: the MedUni Vienna study, published in The FASEB Journal in the USA by Katarzyna Niespodziana ...

New treatment for malaria tertiana

May 3, 2012
“Malaria tertiana is the form of malaria that science needs to focus on in more detail in future.” These are the words of Harald Noedl from the Institute of Specific Prophylaxis and Tropical Medicine at the Medical ...

Bionic leg undergoing clinical trials

April 22, 2011
(Medical Xpress) -- A "bionic" leg designed for people who have lost a lower leg is undergoing clinical trials sponsored by the US Army. The researchers hope the leg will be able to learn the patient's nerve signal patterns ...

Mechanism for more efficient cancer treatment decoded

January 19, 2012
(Medical Xpress) -- A research team from the Institute for Cancer Research at the MedUni Vienna has decoded a previously unknown mechanism of the active ingredient imiquimod in tumour defence. They have been able to prove ...

New methods enable the early detection of Achilles tendon damage

January 31, 2012
Two biochemical methods, developed at the Centre of Excellence for High Field Magnetic Resonance at the MedUni Vienna by Vladimir Juras from the University Department of Radiodiagnostics, are enabling Achilles tendon damage ...

Recommended for you

World's first child hand transplant a 'success'

July 19, 2017
The first child in the world to undergo a double hand transplant is now able to write, feed and dress himself, doctors said Tuesday, declaring the ground-breaking operation a success after 18 months.

Knee surgery—have we been doing it wrong?

July 18, 2017
A team of University at Buffalo medical doctors have published a study that challenges a surgical practice used for decades during arthroscopic knee surgery.

New tools help surgeons find liver tumors, not nick blood vessels

July 17, 2017
The liver is a particularly squishy, slippery organ, prone to shifting both deadly tumors and life-preserving blood vessels by inches between the time they're discovered on a CT scan and when the patient is lying on an operating ...

Researchers discover indicator of lung transplant rejection

July 13, 2017
Research by scientists at Dignity Health St. Joseph's Hospital and Medical Center's Norton Thoracic Institute was published in the July 12, 2017 issue of Science Translational Medicine titled "Zbtb7a induction in alveolar ...

New device could make closing surgical incisions a cinch

July 7, 2017
Like many surgeons, Dr. Jason Spector is often faced with the challenge of securely closing the abdominal wall without injuring the intestines. If the process goes awry, there can be serious consequences for patients, including ...

Success with first 20 patients undergoing minimally invasive pancreatic transplant surgery

June 29, 2017
Surgeons at Johns Hopkins Medicine report that their first series of a minimally invasive procedure to treat chronic pancreas disease, known as severe pancreatitis, resulted in shorter hospital stays, less need for opioids ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.